The Maastricht Transplant Center: clinical setting and epitope searches in HLA class II molecules: does the structural localization of a polymorphic site contribute to its immunogenicity?

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Transplant Immunology

• Publication date

  2014-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.trim.2014.09.002PMID 25240735
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ten years follow-up data of Tac QD (Advagraf) treated renal transplant patients

  2014cited by this paper
• Acceptable mismatching at the class II epitope level: the Canadian experience

  2014cited by this paper
• Sequence-based typing of HLA: an improved group-specific full-length gene sequencing approach.

  2014cited by this paper
• Allele and haplotype frequencies of HLA-DPA1 and -DPB1 in the population of Guadeloupe.

  2014cited by this paper
• HLA epitope based matching for transplantation.

  2014cited by this paper
• First report on the antibody verification of HLA-ABC epitopes recorded in the website-based HLA Epitope Registry.

  2014cited by this paper
• DQ molecules are the principal stimulators of de novo donor‐specific antibodies in nonsensitized pediatric recipients receiving a first kidney transplant

  2014cited by this paper
• Toward HLA Epitope Matching in Clinical Transplantation

  2013cited by this paper
• Current role of human leukocyte antigen matching in kidney transplantation

  2013cited by this paper
• The IMGT/HLA database

  2012cited by this paper
• De Novo DQ Donor-Specific Antibodies Are Associated With a Significant Risk of Antibody-Mediated Rejection and Transplant Glomerulopathy

  2012cited by this paper
• Prevention of antibody‐mediated kidney transplant rejection

  2012cited by this paper
• Evolution and Clinical Pathologic Correlations of De Novo Donor‐Specific HLA Antibody Post Kidney Transplant

  2012cited by this paper
• The antibody response to an HLA mismatch: a model for nonself–self discrimination in relation to HLA epitope immunogenicity

  2012cited by this paper
• Donor-specific HLA-DQ antibodies may contribute to poor graft outcome after renal transplantation.

  2012cited by this paper
• Long‐term follow up for anti‐HLA donor specific antibodies postrenal transplantation: high immunogenicity of HLA class II graft molecules

  2011cited by this paper
• HLA antibodies : detection and clinical relevance

  2011cited by this paper
• HLA-DP antibodies before and after renal transplantation.

  2010cited by this paper
• Human Monoclonal Antibody Reactivity With Human Leukocyte Antigen Class I Epitopes Defined by Pairs of Mismatched Eplets and Self-Eplets

  2010cited by this paper
• Chronic humoral rejection mediated by anti-HLA-DP alloantibodies: insights into the role of epitope sharing in donor-specific and non-donor specific alloantibodies generation.

  2009cited by this paper
• Influence of Immunosuppressive Regimens on Graft Survival and Secondary Outcomes After Kidney Transplantation

  2009cited by this paper
• The IMGT/HLA database

  2008cited by this paper
• Retransplant candidates have donor-specific antibodies that react with structurally defined HLA-DR,DQ,DP epitopes.

  2008cited by this paper
• Non-heartbeating donation of kidneys for transplantation

  2007cited by this paper
• Preformed donor-directed anti-HLA-DP antibodies may be an impediment to successful kidney transplantation.

  2007cited by this paper
• Epitopes of the HLA-A, B, C, DR, DQ and MICA antigens.

  2007cited by this paper
• One‐Year Results with Extended‐Release Tacrolimus/MMF, Tacrolimus/MMF and Cyclosporine/MMF in De Novo Kidney Transplant Recipients

  2007cited by this paper
• Human Leukocyte Antigen Class I Epitopes: Update to 103 Total Epitopes, Including the C Locus

  2007cited by this paper
• HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. V. Eplet matching for HLA-DR, HLA-DQ, and HLA-DP.

  2007cited by this paper
• DP reactive antibody in a zero mismatch renal transplant pair.

  2007cited by this paper
• Immunosuppression: Evolution in Practice and Trends, 1994–2004

  2006cited by this paper
• A structurally based approach to determine HLA compatibility at the humoral immune level.

  2006cited by this paper
• High rejection rate during calcineurin inhibitor-free and early steroid withdrawal immunosuppression in renal transplantation.

  2006cited by this paper
• HLA class I epitopes: A and B loci.

  2006cited by this paper
• Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data

  2005cited by this paper
• HLAMatchmaker-based analysis of human monoclonal antibody reactivity demonstrates the importance of an additional contact site for specific recognition of triplet-defined epitopes.

  2005cited by this paper
• Predicting Kidney Graft Failure by HLA Antibodies: a Prospective Trial

  2004cited by this paper
• Cancer after Kidney Transplantation in the United States

  2004cited by this paper
• Incidence of cancer after kidney transplant: results from the North Italy transplant program

  2003cited by this paper
• The natural history of chronic allograft nephropathy.

  2003cited by this paper
• A new epitope-based HLA-DPB matching approach for cadaver kidney retransplants

  2003cited by this paper
• Early steroid withdrawal in renal transplantation with tacrolimus dual therapy: a pilot study

  2002cited by this paper
• HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. II. Verification of the algorithm and determination of the relative immunogenicity of amino acid triplet-defined epitopes.

  2002cited by this paper
• Strategies to improve long-term outcomes after renal transplantation.

  2002cited by this paper
• HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. I. Description of the algorithm.

  2002cited by this paper
• Genetic variability and linkage disequilibrium within the HLA-DP region: analysis of 15 different populations.

  2001cited by this paper
• The HLA dictionary 2001: a summary of HLA-A, -B, -C, -DRB1/3/4/5, -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR, and -DQ antigens.

  2001cited by this paper
• Single-center experience with tacrolimus versus cyclosporine-Neoral in renal transplant recipients

  2001cited by this paper
• The HLA Dictionary 2001: a summary of HLA-A, -B, -C, -DRB1/3/4/5 and -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR and -DQ antigens.

  2001cited by this paper
• Long-term survival in renal transplant recipients with graft function.

  2000cited by this paper
• Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant.

  1999cited by this paper
• Overview of the epidemiology of immunodeficiency-associated cancers.

  1998cited by this paper
• Measurement of antigen–antibody interactions with biosensors

  1998cited by this paper
• HLA-DP epitope typing using monoclonal antibodies.

  1998cited by this paper
• Clinical relevance of HLA-DPB locus matching for cadaver kidney retransplants: a report of the Collaborative Transplant Study.

  1997cited by this paper
• The non heart-beating donor.

  1996cited by this paper
• No advantage of flow cytometry crossmatch over complement-dependent cytotoxicity in immunologically well-documented renal allograft recipients.

  1996cited by this paper
• Retrospective analysis of the outcome of transplantation of non-heart-beating donor kidneys.

  1995cited by this paper
• Outcome of transplantation of non-heart-beating donor kidneys.

  1995cited by this paper
• Cloned primed lymphocyte test cells recognize the fourth, fifth, and sixth hypervariable regions at amino acid positions 65-87 of the DPB1 molecule.

  1995cited by this paper
• Nonheart-beating donors: the Maastricht experience.

  1994cited by this paper
• Isolated HLA-DP mismatches between donors and recipients do not influence the function or outcome of renal transplants.

  1992cited by this paper
• Crucial role of the third and fourth hypervariable regions of HLA-DPB1 allelic sequences in the mixed lymphocyte reaction.

  1992cited by this paper
• DP epitope mapping by using T-cell clones.

  1992cited by this paper
• HLA class II nucleotide sequences, 1991.

  1991cited by this paper
• HLA class II nucleotide sequences, 1991

  1991cited by this paper
• PRECISE SPECIFICITY OF INDUCED TUBULAR HLA‐CLASS II ANTIGENS IN RENAL ALLOGRAFTS

  1987cited by this paper
• Identification of HLA-DP polymorphism with DP alpha and DP beta probes and monoclonal antibodies: correlation with primed lymphocyte typing.

  1987cited by this paper
• Non-heartbeating donors, is it worthwhile?

  1980cited by this paper

• MODELS OF HLA-DPB1 PERMISSIVENESS AND UNRELATED DONOR HEMATOPOIETIC CELL TRANSPLANTATION

  2024cites this paper
• The role of HLA-DP mismatches and donor specific HLA-DP antibodies in kidney transplantation: A case series.

  2020cites this paper
• Allelic and Epitopic Characterization of Intra–Kidney Allograft Anti‐HLA Antibodies at Allograft Nephrectomy

  2017cites this paper
• Are We Ready for Epitope-Based HLA Matching in Clinical Organ Transplantation?

  2017cites this paper